The OTC markets can be a thrilling environment for investors to find emerging companies and potentially lucrative opportunities. OTC stocks are often associated with small, early-stage companies, but they can offer investors the chance to invest in companies with significant growth potential.

In this article, we'll be taking a closer look at four OTC stocks that can provide an entry point for investors who are looking for lower-cost stock options with upside potential.

Epazz, Inc. (OTC: EPAZ) is a provider of drone technology and blockchain mobile apps. In this article, we will be focusing on the company's drone spinoff, ZenaDrone. EPAZ has been prioritizing the development of the ZenaDrone 1000, a flagship drone equipped with machine learning systems, multispectral sensors, and AI technology.

Last week, EPAZ announced that ZenaDrone is expanding its production facilities in Dubai to fulfill its obligations under several pilot program agreements and schedule demonstrations of its drone.

The drone is designed for use in the military, as well as the oil and gas and agriculture industries. The ZenaDrone 1000 is adaptable across many industries as it has the ability to use the data captured from its cameras to create 3D interactive environment maps and learn from these maps, harnessing the power of AI.

In 2022, ZenaDrone produced 10 ZenaDrone 1000. According to the company, this year's goal is to produce over 20 drones per month, with the capacity to produce 40 in the same facility.

CEO Shaun Passley, Ph.D., said, "We are encouraged by the level of interest we have received and, based on the pilot program agreements and the number of scheduled demonstrations, that it is time to expand to double the size of our production facility."

Over the past six months, the company has been taking steps to promote the use of the ZenaDrone 1000 by the US military, including submitting Phase 1 SBIR proposals to the U.S. government and presenting ZenaDrone in front of various branches of the U.S. military.

On March 28, ZenaDrone received a letter of support from the U.S. Air Force to use ZenaDrone 1000 for drone cargo delivery, which includes blood transport. EPAZ has been invited to work with the U.S. Air Force at an overseas base to test the ZenaDrone 1000 platform under battlefield conditions, and it will be assigned a team from the base to conduct the test.

EPAZ recently announced that ZenaDrone has reached Technology Readiness Level 7, a significant milestone for the company's drone technology. This achievement qualifies ZenaDrone to submit a Phase II SBIR grant for external funding of its cargo delivery solution, which could provide a non-dilutive source of funding of up to $1.2 million for a two-year period. This is the second direct to Phase II project for ZenaDrone, indicating the company's continued progress and development in the industry. This news showcases the potential for ZenaDrone to continue growing and expanding its reach in the market.

ZenaDrone is in the process of qualifying for Green UAS certification, which is a new US government compliance program and a crucial step for becoming a government provider of drone technology.

The expansion of ZenaDrone's production facilities in Dubai and its efforts to promote the use of the ZenaDrone 1000 by the US military demonstrate Epazz's commitment to the development and success of its drone technology. With its adaptability across multiple industries and potential applications, the ZenaDrone 1000 could prove to be a significant player in the future of drone technology.

Zerify Inc. (OTC: ZRFY) is a leading provider of cybersecurity solutions with more than 20 years of experience in the industry. The ZRFY suite of products and services helps prevent cyber theft and data security breaches for individuals, corporations, and government agencies using multi-factor out-of-band authentication, keystroke encryption, and mobile solutions.

One of Zerify's standout products is a web-based video conferencing solution that requires no desktop installation. The platform offers advanced security measures, including anti-screen capture, keystroke protection, and push and biometric authentication. The platform's five-level meeting security control approach is designed to protect sensitive information, making it an excellent choice for businesses seeking secure communication options.

This week, ZRFY announced that it is integrating the advanced language processing and natural language understanding capabilities of ChatGPT, a state-of-the-art language model developed by OpenAI, into its Zerify Meet Secure Video Conferencing Software.

With this integration, users will be able to communicate more effectively and efficiently during video conferences, improving collaboration, productivity, and reducing misunderstandings. The addition of ChatGPT to Zerify Meet marks a significant step in providing businesses with tools to collaborate and communicate more securely and efficiently. Zerify is also exploring the possibility of adding AI capabilities to its Zerify Defender endpoint security software.

Artificial Intelligence Technology Solutions Inc. (OTC: AITX) is a company focused on providing innovative AI-driven security solutions and is disrupting the $25 billion security and guarding services industry through its subsidiary, Robotic Assistance Devices, Inc.

When compared to traditional manned security models, RAD offers cost-effective Solutions-as-a-Service that can save businesses between 35% and 80%. Their suite of stationary and mobile robotic solutions is intended to supplement and replace human personnel in appropriate environments.

All RAD technologies, including AI-based analytics and software platforms, are developed in-house. With a sales pipeline of over 35 Fortune 500 companies and numerous other potential clients, RAD is poised for growth and recurring revenue as it converts existing sales opportunities into deployed clients

On the 18th, RAD announced that it had secured an order for 11 ROSA security robots and 2 AVA access control solutions. The order was facilitated by one of RAD's largest national authorized dealers and will be deployed at a large warehouse center belonging to a Fortune 250-ranked supplier of technology-driven solutions for the global energy industry.

The robots will be responsible for detecting and deterring security breaches such as trespassing and loitering. One of the AVA units will replace a security guard at a secure entrance gate, while the remaining AVA unit will supplement the tasks of another security guard at a gated entrance to the facility.

The deployment is estimated to replace human labor valued at $400,000 to $600,000 annually. RAD expects to deliver the full 13-unit order to the project site by the end of April 2023 and plans to begin invoicing for the deployment in May or June. The company also noted that it is making significant progress in fulfilling backlogged orders.

This order further highlights the growing demand for AITX's innovative security solutions as the company continues to expand its presence in the industry and attract new clients.

Evofem Biosciences, Inc. (OTC: EVFM), which is a company focused on developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, Its flagship product, Phexxi, is the first FDA-approved hormone-free, on-demand prescription contraceptive vaginal gel. The product is applied 0-60 minutes before each act of sex and is available in a box of 12 pre-filled applicators.

In recent news for the company, EVFM has appointed Ivy Zhang as its Chief Financial Officer (CFO) and Secretary, effective April 13, 2023. Zhang, who previously served as Director of SEC Reporting and SOX Compliance at Evofem from March 2018. Zhang will lead the company's finance organization and financial activities.

Zhang is expected to support the company's operations as it works towards its goal of being EBITDA breakeven on a quarterly basis by the end of this year. Zhang is an accomplished finance executive with over 14 years of financial and accounting experience in a variety of industries, including pharmaceuticals and medical devices. She returns to Evofem after serving as Vice President and Controller at Huyabio International since November 2022.

For Evofem Biosciences, Inc., and its investors, the hiring of Ivy Zhang as CFO and Secretary could be a good development. Zhang will be an asset to Evofem's operations as it works to achieve its objective of being EBITDA breakeven on a quarterly basis by the end of this year thanks to his vast experience in financial and accounting roles in the pharmaceutical and medical device industries.

The hiring of Zhang also represents a continuation of Evofem's entrepreneurial spirit and growth mindset, which are important components in the business's ongoing success. Keep an eye on EVFM as the company continues to develop and commercialize innovative products to address unmet needs in women's sexual and reproductive health.

Disclaimers:CapitalGainsReport (CGR) is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. CapitalGainsReport (CGR) is owned by RazorPitch Inc. and has been retained by Epazz Inc. to assist in the production and distribution of content. 'CGR' is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by CapitalGainsReport/RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. CGR/RazorPitch is not a fiduciary by virtue of any persons use of or access to this content.

CONTACT: CapitalGainsReport

Mark McKelvie

Editor

Markrmckelvie@gmail.com

585-301-7700

.

(C) 2023 M2 COMMUNICATIONS, source M2 PressWIRE